Simvastatin in traumatic brain injury: effect on brain edema mechanisms
Traumatic brain injury causes deleterious brain edema, leading to high mortality and morbidity. Brain edema exacerbates neurologic deficits and may be attributable to the breakdown of endothelial cell junction protein, leukocyte infiltration, and matrix metalloproteinase activation. These all contri...
Gespeichert in:
| Veröffentlicht in: | Critical care medicine Jg. 39; H. 10; S. 2300 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.10.2011
|
| Schlagworte: | |
| ISSN: | 1530-0293, 1530-0293 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Traumatic brain injury causes deleterious brain edema, leading to high mortality and morbidity. Brain edema exacerbates neurologic deficits and may be attributable to the breakdown of endothelial cell junction protein, leukocyte infiltration, and matrix metalloproteinase activation. These all contribute to loss of blood-brain barrier integrity. The pleiotropic effects of statins, hydroxymethylglutaryl-coenzyme A reductase inhibitors, may inhibit posttraumatic brain edema. We therefore investigated the effect of acute simvastatin on neurologic deficits, cerebral edema, and its origins.
Randomized laboratory animal study.
University-affiliated research laboratory.
Male Sprague-Dawley rats.
Rats were subjected to lateral fluid percussion traumatic brain injury. Our preliminary dose-effect study indicated that 37.5 mg/kg simvastatin, administered orally 1 hr and 6 hrs after traumatic brain injury, has the greatest anti-edematous effect. This dose was used to study its effects on brain edema and on its mechanisms.
We first assessed the effects of simvastatin 24 hrs after traumatic brain injury on brain edema, brain claudin-5 expression, and the vascular endothelial-cadherin (pTyr731)/total vascular endothelial-cadherin ratio, matrix metalloproteinase-9 activity, intercellular adhesion molecule-1 expression, and polymorphonuclear neutrophil infiltration. We also evaluated blood-brain barrier permeability by measuring Evans blue and fluorescein sodium salt extravasation into the cerebral parenchyma. We then investigated whether simvastatin reduces neurologic deficits, edema, and blood-brain barrier permeability earlier than 24 hrs; these effects were evaluated 6 hrs after traumatic brain injury. The anti-edematous effect of simvastatin 24 hrs after traumatic brain injury was associated with increased claudin-5 and decreased intercellular adhesion molecule-1, polymorphonuclear neutrophil infiltration, and blood-brain barrier permeability, with no effect on matrix metalloproteinase-9 activity or vascular endothelial-cadherin phosphorylation. Earlier, 6-hrs after traumatic brain injury, simvastatin reduced neurologic deficits, cerebral edema, and blood-brain barrier permeability.
Simvastatin could be a new therapy for reducing posttraumatic edema by preventing damage to tight junctions and neutrophil infiltration into the parenchyma, thus preserving blood-brain barrier integrity. |
|---|---|
| AbstractList | Traumatic brain injury causes deleterious brain edema, leading to high mortality and morbidity. Brain edema exacerbates neurologic deficits and may be attributable to the breakdown of endothelial cell junction protein, leukocyte infiltration, and matrix metalloproteinase activation. These all contribute to loss of blood-brain barrier integrity. The pleiotropic effects of statins, hydroxymethylglutaryl-coenzyme A reductase inhibitors, may inhibit posttraumatic brain edema. We therefore investigated the effect of acute simvastatin on neurologic deficits, cerebral edema, and its origins.
Randomized laboratory animal study.
University-affiliated research laboratory.
Male Sprague-Dawley rats.
Rats were subjected to lateral fluid percussion traumatic brain injury. Our preliminary dose-effect study indicated that 37.5 mg/kg simvastatin, administered orally 1 hr and 6 hrs after traumatic brain injury, has the greatest anti-edematous effect. This dose was used to study its effects on brain edema and on its mechanisms.
We first assessed the effects of simvastatin 24 hrs after traumatic brain injury on brain edema, brain claudin-5 expression, and the vascular endothelial-cadherin (pTyr731)/total vascular endothelial-cadherin ratio, matrix metalloproteinase-9 activity, intercellular adhesion molecule-1 expression, and polymorphonuclear neutrophil infiltration. We also evaluated blood-brain barrier permeability by measuring Evans blue and fluorescein sodium salt extravasation into the cerebral parenchyma. We then investigated whether simvastatin reduces neurologic deficits, edema, and blood-brain barrier permeability earlier than 24 hrs; these effects were evaluated 6 hrs after traumatic brain injury. The anti-edematous effect of simvastatin 24 hrs after traumatic brain injury was associated with increased claudin-5 and decreased intercellular adhesion molecule-1, polymorphonuclear neutrophil infiltration, and blood-brain barrier permeability, with no effect on matrix metalloproteinase-9 activity or vascular endothelial-cadherin phosphorylation. Earlier, 6-hrs after traumatic brain injury, simvastatin reduced neurologic deficits, cerebral edema, and blood-brain barrier permeability.
Simvastatin could be a new therapy for reducing posttraumatic edema by preventing damage to tight junctions and neutrophil infiltration into the parenchyma, thus preserving blood-brain barrier integrity. Traumatic brain injury causes deleterious brain edema, leading to high mortality and morbidity. Brain edema exacerbates neurologic deficits and may be attributable to the breakdown of endothelial cell junction protein, leukocyte infiltration, and matrix metalloproteinase activation. These all contribute to loss of blood-brain barrier integrity. The pleiotropic effects of statins, hydroxymethylglutaryl-coenzyme A reductase inhibitors, may inhibit posttraumatic brain edema. We therefore investigated the effect of acute simvastatin on neurologic deficits, cerebral edema, and its origins.OBJECTIVESTraumatic brain injury causes deleterious brain edema, leading to high mortality and morbidity. Brain edema exacerbates neurologic deficits and may be attributable to the breakdown of endothelial cell junction protein, leukocyte infiltration, and matrix metalloproteinase activation. These all contribute to loss of blood-brain barrier integrity. The pleiotropic effects of statins, hydroxymethylglutaryl-coenzyme A reductase inhibitors, may inhibit posttraumatic brain edema. We therefore investigated the effect of acute simvastatin on neurologic deficits, cerebral edema, and its origins.Randomized laboratory animal study.DESIGNRandomized laboratory animal study.University-affiliated research laboratory.SETTINGSUniversity-affiliated research laboratory.Male Sprague-Dawley rats.SUBJECTSMale Sprague-Dawley rats.Rats were subjected to lateral fluid percussion traumatic brain injury. Our preliminary dose-effect study indicated that 37.5 mg/kg simvastatin, administered orally 1 hr and 6 hrs after traumatic brain injury, has the greatest anti-edematous effect. This dose was used to study its effects on brain edema and on its mechanisms.INTERVENTIONSRats were subjected to lateral fluid percussion traumatic brain injury. Our preliminary dose-effect study indicated that 37.5 mg/kg simvastatin, administered orally 1 hr and 6 hrs after traumatic brain injury, has the greatest anti-edematous effect. This dose was used to study its effects on brain edema and on its mechanisms.We first assessed the effects of simvastatin 24 hrs after traumatic brain injury on brain edema, brain claudin-5 expression, and the vascular endothelial-cadherin (pTyr731)/total vascular endothelial-cadherin ratio, matrix metalloproteinase-9 activity, intercellular adhesion molecule-1 expression, and polymorphonuclear neutrophil infiltration. We also evaluated blood-brain barrier permeability by measuring Evans blue and fluorescein sodium salt extravasation into the cerebral parenchyma. We then investigated whether simvastatin reduces neurologic deficits, edema, and blood-brain barrier permeability earlier than 24 hrs; these effects were evaluated 6 hrs after traumatic brain injury. The anti-edematous effect of simvastatin 24 hrs after traumatic brain injury was associated with increased claudin-5 and decreased intercellular adhesion molecule-1, polymorphonuclear neutrophil infiltration, and blood-brain barrier permeability, with no effect on matrix metalloproteinase-9 activity or vascular endothelial-cadherin phosphorylation. Earlier, 6-hrs after traumatic brain injury, simvastatin reduced neurologic deficits, cerebral edema, and blood-brain barrier permeability.MEASUREMENTS AND MAIN RESULTSWe first assessed the effects of simvastatin 24 hrs after traumatic brain injury on brain edema, brain claudin-5 expression, and the vascular endothelial-cadherin (pTyr731)/total vascular endothelial-cadherin ratio, matrix metalloproteinase-9 activity, intercellular adhesion molecule-1 expression, and polymorphonuclear neutrophil infiltration. We also evaluated blood-brain barrier permeability by measuring Evans blue and fluorescein sodium salt extravasation into the cerebral parenchyma. We then investigated whether simvastatin reduces neurologic deficits, edema, and blood-brain barrier permeability earlier than 24 hrs; these effects were evaluated 6 hrs after traumatic brain injury. The anti-edematous effect of simvastatin 24 hrs after traumatic brain injury was associated with increased claudin-5 and decreased intercellular adhesion molecule-1, polymorphonuclear neutrophil infiltration, and blood-brain barrier permeability, with no effect on matrix metalloproteinase-9 activity or vascular endothelial-cadherin phosphorylation. Earlier, 6-hrs after traumatic brain injury, simvastatin reduced neurologic deficits, cerebral edema, and blood-brain barrier permeability.Simvastatin could be a new therapy for reducing posttraumatic edema by preventing damage to tight junctions and neutrophil infiltration into the parenchyma, thus preserving blood-brain barrier integrity.CONCLUSIONSSimvastatin could be a new therapy for reducing posttraumatic edema by preventing damage to tight junctions and neutrophil infiltration into the parenchyma, thus preserving blood-brain barrier integrity. |
| Author | Marchand-Leroux, Catherine Fréchou, Magalie Plotkine, Michel Ru Chen, Xiao Soustrat, Mathieu El Shafey, Nelly Margaill, Isabelle Teng, Fei Beray-Berthat, Virginie Béziaud, Tiphaine Palmier, Bruno Besson, Valérie C |
| Author_xml | – sequence: 1 givenname: Tiphaine surname: Béziaud fullname: Béziaud, Tiphaine organization: Université Paris Descartes, Laboratoire de Pharmacologie de la Circulation Cérébrale EA4475, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France – sequence: 2 givenname: Xiao surname: Ru Chen fullname: Ru Chen, Xiao – sequence: 3 givenname: Nelly surname: El Shafey fullname: El Shafey, Nelly – sequence: 4 givenname: Magalie surname: Fréchou fullname: Fréchou, Magalie – sequence: 5 givenname: Fei surname: Teng fullname: Teng, Fei – sequence: 6 givenname: Bruno surname: Palmier fullname: Palmier, Bruno – sequence: 7 givenname: Virginie surname: Beray-Berthat fullname: Beray-Berthat, Virginie – sequence: 8 givenname: Mathieu surname: Soustrat fullname: Soustrat, Mathieu – sequence: 9 givenname: Isabelle surname: Margaill fullname: Margaill, Isabelle – sequence: 10 givenname: Michel surname: Plotkine fullname: Plotkine, Michel – sequence: 11 givenname: Catherine surname: Marchand-Leroux fullname: Marchand-Leroux, Catherine – sequence: 12 givenname: Valérie C surname: Besson fullname: Besson, Valérie C |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21666443$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNT8tKw0AUHaRiH_oHItm5Sr3zSGbiToJWoeJCXYc7MzeY0klqJhH69xatIBw4Dw4HzpxN2q4lxi45LDkU-qYsn5dggUuS3AghNCk8YTOeSUhBFHLyT0_ZPMYNAFeZlmdsKnie50rJGVu9NuEL44BD0yYHDD2O4WBcYnv8iTZjv79NqK7JDUnXHnPyFDAJ5D6wbWKI5-y0xm2kiyMv2PvD_Vv5mK5fVk_l3Tp1iheYemuUVZ5zLQG1EVYqIQ2C8Qa8k1Y4zDxYq5y2nowDI0xmC7RU59plXizY9e_uru8-R4pDFZroaLvFlroxVqaQmhd5AYfm1bE52kC-2vVNwH5f_X0X30YfXyI |
| CitedBy_id | crossref_primary_10_3109_00207454_2012_704455 crossref_primary_10_1002_mabi_202200577 crossref_primary_10_1097_CCM_0000000000001425 crossref_primary_10_3390_ijms160611903 crossref_primary_10_1016_j_jss_2013_11_1106 crossref_primary_10_3109_02699052_2016_1147599 crossref_primary_10_1165_rcmb_2013_0058OC crossref_primary_10_3390_ijms231911193 crossref_primary_10_5812_ans_106867 crossref_primary_10_1155_2012_292598 crossref_primary_10_1002_phar_1272 crossref_primary_10_1007_s12035_021_02436_4 crossref_primary_10_1089_neu_2013_3019 crossref_primary_10_1016_j_expneurol_2015_05_024 crossref_primary_10_1016_j_jns_2014_04_032 crossref_primary_10_1089_neu_2015_4130 crossref_primary_10_1016_j_biopha_2017_08_125 crossref_primary_10_1080_02699052_2020_1802663 crossref_primary_10_1007_s12975_020_00794_0 crossref_primary_10_26641_2307_0404_2024_2_307690 crossref_primary_10_1111_fcp_12656 crossref_primary_10_3390_antiox9121269 crossref_primary_10_1186_cc10921 crossref_primary_10_1016_j_mvr_2013_03_004 crossref_primary_10_2217_fnl_2016_0032 crossref_primary_10_1007_s43440_024_00582_9 crossref_primary_10_1016_j_brainres_2016_01_055 crossref_primary_10_1186_s12974_024_03118_3 crossref_primary_10_1097_JTN_0000000000000026 crossref_primary_10_2147_NDT_S480921 crossref_primary_10_1097_HTR_0000000000000369 crossref_primary_10_1016_j_resp_2018_05_006 crossref_primary_10_1016_j_ntt_2014_06_004 crossref_primary_10_3892_etm_2016_3022 crossref_primary_10_23736_S0021_9509_22_12437_7 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/CCM.0b013e3182227e4a |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1530-0293 |
| ExternalDocumentID | 21666443 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 1J1 354 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6J9 6PF 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AAQQT AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABPPZ ABPXF ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACLDA ACOAL ACWDW ACWRI ACXJB ACXNZ ACZKN ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFMBP AFNMH AFSOK AFUWQ AGINI AHOMT AHQNM AHQVU AHRYX AHVBC AI. AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BOYCO BQLVK BS7 BYPQX C45 CGR CS3 CUY CVF DIWNM DU5 DUNZO E.X EBS ECM EEVPB EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI L-C L7B M18 N4W N9A NEJ NPM N~7 N~B N~M O9- OAG OAH OB4 OBH OCUKA ODA ODMTH ODZKP OHH OHT OHYEH OL1 OLB OLG OLH OLU OLV OLY OLZ ONV OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PONUX R58 RIG RLZ S4R S4S T8P TEORI TSPGW V2I VH1 VVN W3M WOQ WOW X3V X3W X7M XXN XYM YFH YOC YOJ ZCG ZFV ZGI ZXP ZY1 ZZMQN ~9M 7X8 ACBKD ADKSD |
| ID | FETCH-LOGICAL-c419a-db84b4d11730a782b34238a08d80dc3b2ca5d0bb4c7bde8c08285b9abef67c5d2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 46 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000294958500014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1530-0293 |
| IngestDate | Sun Nov 09 12:35:35 EST 2025 Mon Jul 21 06:04:03 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c419a-db84b4d11730a782b34238a08d80dc3b2ca5d0bb4c7bde8c08285b9abef67c5d2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 21666443 |
| PQID | 893719690 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_893719690 pubmed_primary_21666443 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-October |
| PublicationDateYYYYMMDD | 2011-10-01 |
| PublicationDate_xml | – month: 10 year: 2011 text: 2011-October |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Critical care medicine |
| PublicationTitleAlternate | Crit Care Med |
| PublicationYear | 2011 |
| SSID | ssj0014573 |
| Score | 2.2551582 |
| Snippet | Traumatic brain injury causes deleterious brain edema, leading to high mortality and morbidity. Brain edema exacerbates neurologic deficits and may be... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 2300 |
| SubjectTerms | Animals Antigens, CD - biosynthesis Blood-Brain Barrier - metabolism Brain Edema - drug therapy Brain Edema - etiology Brain Edema - pathology Brain Injuries - complications Cadherins - biosynthesis Claudin-5 Endothelial Cells - metabolism Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology Intercellular Adhesion Molecule-1 - biosynthesis Male Matrix Metalloproteinase 9 - biosynthesis Membrane Proteins - biosynthesis Neutrophils - drug effects Neutrophils - pathology Rats Rats, Sprague-Dawley Simvastatin - pharmacology |
| Title | Simvastatin in traumatic brain injury: effect on brain edema mechanisms |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/21666443 https://www.proquest.com/docview/893719690 |
| Volume | 39 |
| WOSCitedRecordID | wos000294958500014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agv9uB16SbZJBsvIsXqpaWgQm9hH1OI0KQ2bX-_s3nYk3gQQg4LgTA7s_Ox3zczhNxPo1goJcDJBiUTRluWGBEw7VtQgBCaR9Nq2EQ8GsnJJBk32pyykVW2Z2J1UNvCuDvynsurrpULf5x_MTc0ypGrzQSNbdIJEMk4RVc82ZAIIqwIZoxpzjimtbZyLol7_f5wcwXoykFBqN8xZpVrBof__MsjctCATPpUe8Ux2YL8hOwNGxr9lLy8ZbO1crVEWU7xWS7UqmrdSrWbGIFLn2jqB1qLPWiRN-tgYaboDFy1cFbOyjPyMXh-77-yZqICM8JLFLNaCi2s52FcK8QG2vX_k4pLK7k1gfaNCi3XWphYW5Cm6m-nE6UB99SE1j8nO3mRwyWhIuIWtznAvdYCPE8nQWhlov3IAkKsqEtoa6EUPdbRECqHYlWmPzbqkovayum87qyR-o7EFCK4-vvja7Lvt3I874Z0phitcEt2zXqZlYu7yhPwPRoPvwFBir2e |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Simvastatin+in+traumatic+brain+injury%3A+effect+on+brain+edema+mechanisms&rft.jtitle=Critical+care+medicine&rft.au=B%C3%A9ziaud%2C+Tiphaine&rft.au=Ru+Chen%2C+Xiao&rft.au=El+Shafey%2C+Nelly&rft.au=Fr%C3%A9chou%2C+Magalie&rft.date=2011-10-01&rft.issn=1530-0293&rft.eissn=1530-0293&rft.volume=39&rft.issue=10&rft.spage=2300&rft_id=info:doi/10.1097%2FCCM.0b013e3182227e4a&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-0293&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-0293&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-0293&client=summon |